Cargando…
Registered report: BET bromodomain inhibition as a therapeutic strategy to target c-Myc
The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by replicating selected results from a substantial number of high-profile papers in the field of cancer biology published between 2010 and 2012. This Registered report describes...
Autores principales: | Kandela, Irawati, Jin, Hyun Yong, Owen, Katherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480271/ https://www.ncbi.nlm.nih.gov/pubmed/26111384 http://dx.doi.org/10.7554/eLife.07072 |
Ejemplares similares
-
Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc
por: Aird, Fraser, et al.
Publicado: (2017) -
Correction: Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc
por: Aird, Fraser, et al.
Publicado: (2018) -
Registered report: Discovery and preclinical validation of drug
indications using compendia of public gene expression data
por: Kandela, Irawati, et al.
Publicado: (2015) -
Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs
por: Kandela, Irawati, et al.
Publicado: (2015) -
Correction: Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs
por: Kandela, Irawati, et al.
Publicado: (2015)